Estrella Immunopharma, Inc.
ESLA
$0.7936
-$0.0428-5.12%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -56.85% | -11.89% | -47.74% | -59.14% | 792.99% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 51.52% | -92.61% | 873.60% | 189.05% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -49.82% | -48.41% | -8.62% | -65.46% | 893.74% |
|
|
|||||
| Total Current Assets | -49.82% | -48.41% | -8.62% | -65.46% | 893.74% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -16.14% | -48.41% | -8.62% | -65.46% | 803.11% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -99.17% | -- |
| Total Accrued Expenses | 2,065.41% | 45.18% | 2,022.73% | -99.82% | -71.70% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 0.00% | 0.00% | -33.33% | -75.00% | 9.09% |
| Total Finance Division Other Current Liabilities | 6.08% | 0.00% | -86.80% | -93.91% | 478.93% |
| Total Other Current Liabilities | 6.08% | 0.00% | -86.80% | -93.91% | 478.93% |
| Total Current Liabilities | 1,554.07% | 30.47% | -65.26% | -97.69% | 77.09% |
|
|
|||||
| Total Current Liabilities | 1,554.07% | 30.47% | -65.26% | -97.69% | 77.09% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1,554.07% | 30.47% | -65.26% | -97.69% | 76.86% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.00% | 0.00% | 0.00% | 5,309.91% |
| Retained Earnings | -17.32% | -25.41% | -3.11% | -7.26% | -15.35% |
| Treasury Stock & Other | -42.47% | -321.40% | -- | -- | -- |
| Total Common Equity | -82.54% | -49.69% | -6.12% | -10.14% | 185.75% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -82.54% | -49.69% | -6.12% | -10.14% | 185.75% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -82.54% | -49.69% | -6.12% | -10.14% | 249.34% |
|
|
|||||